We are live on
!
Find out more
T
TOBAM Portfolio holdings
AUM
$384M
1-Year Est. Return
10.32%
This Fund
S&P 500
This Quarter
Est. Return
+30.56%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$1.55B
AUM Growth
+$290M
(+23%)
Cap. Flow
+$12.7M
Cap. Flow
% of AUM
0.82%
Top 10 Holdings %
Top 10 Hldgs %
27.14%
Holding
181
New
46
Increased
42
Reduced
54
Closed
38
Top Buys
| 1 |
Conagra Brands
CAG
|
+$34.4M |
| 2 |
Teladoc Health
TDOC
|
+$32.2M |
| 3 |
Gilead Sciences
GILD
|
+$31.6M |
| 4 |
Clorox
CLX
|
+$26.7M |
| 5 |
Moderna
MRNA
|
+$21.7M |
Top Sells
| 1 |
NextEra Energy
NEE
|
+$35.5M |
| 2 |
Edison International
EIX
|
+$32.2M |
| 3 |
Ulta Beauty
ULTA
|
+$20.9M |
| 4 |
AutoZone
AZO
|
+$19.7M |
| 5 |
Newmont
NEM
|
+$18.3M |
Sector Composition
| 1 | Consumer Staples | 24.87% |
| 2 | Healthcare | 18.56% |
| 3 | Consumer Discretionary | 12.54% |
| 4 | Materials | 11.84% |
| 5 | Communication Services | 6.65% |
Similar funds
PCM
DFA
BAMG
DR
GCP
DC
GA
VI
TOBAM's Q2 2020 Portfolio in Review
As of Q2 2020, TOBAM held 181 positions worth $1.55B, up 23% from $1.26B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
TOBAM's Q2 2020 filing shows 46 new, 42 increased, 54 reduced and 38 closed positions. Its largest new stake was Teladoc Health: 183,779 shares worth $35.1M. The largest sale was NextEra Energy, an estimated $35.5M.
By sector, the portfolio is most concentrated in Consumer Staples at 25% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- TOBAM's largest Q2 2020 buy was Teladoc Health: 183,779 shares worth $35.1M.
- TOBAM added most to Conagra Brands in Q2 2020, an estimated $34.4M increase.
- TOBAM's biggest Q2 2020 reduction was NextEra Energy, cutting an estimated $35.5M.
- TOBAM fully exited Ventas in Q2 2020, selling an estimated $14.8M.
- TOBAM's ten largest holdings make up 27% of its $1.55B portfolio in Q2 2020.
- TOBAM opened 46 new positions and closed 38 in Q2 2020.
- TOBAM's portfolio value rose 23% quarter-over-quarter to $1.55B.
Based on TOBAM's 13F filing for Q2 2020, filed 17 Aug 2020.